V. Nuessler

634 total citations
20 papers, 512 citations indexed

About

V. Nuessler is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, V. Nuessler has authored 20 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in V. Nuessler's work include Acute Myeloid Leukemia Research (8 papers), Virus-based gene therapy research (3 papers) and Blood disorders and treatments (3 papers). V. Nuessler is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Virus-based gene therapy research (3 papers) and Blood disorders and treatments (3 papers). V. Nuessler collaborates with scholars based in Germany, Austria and United States. V. Nuessler's co-authors include R. Pelka‐Fleischer, H. Zwierzina, Frank Gieseler, Helga Schmetzer, Helmut R. Salih, Gary C. Starling, Peter A. Kiener, Julian Hickling, Simon Stacey and Harald Sommer and has published in prestigious journals such as The Journal of Immunology, Biochemical Pharmacology and European Journal of Cancer.

In The Last Decade

V. Nuessler

20 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Nuessler Germany 13 218 183 141 139 124 20 512
Robert Bartlett Germany 10 283 1.3× 180 1.0× 84 0.6× 101 0.7× 58 0.5× 12 672
Dieter Hoelzer Germany 8 190 0.9× 231 1.3× 73 0.5× 94 0.7× 109 0.9× 10 591
Simone Jüliger United Kingdom 11 152 0.7× 353 1.9× 81 0.6× 82 0.6× 48 0.4× 13 617
CC Uphoff Germany 9 142 0.7× 234 1.3× 79 0.6× 193 1.4× 172 1.4× 12 586
K. Jurianz Germany 8 312 1.4× 130 0.7× 56 0.4× 81 0.6× 54 0.4× 10 469
Kathy S. Wang United States 9 360 1.7× 126 0.7× 46 0.3× 168 1.2× 125 1.0× 11 588
Aloke Sarkar United States 14 100 0.5× 273 1.5× 107 0.8× 105 0.8× 56 0.5× 20 492
Astrid Zahn Canada 12 184 0.8× 188 1.0× 157 1.1× 64 0.5× 44 0.4× 19 509
E P Rieber Germany 11 268 1.2× 113 0.6× 113 0.8× 54 0.4× 55 0.4× 20 483
Cécile Tétaud France 13 315 1.4× 214 1.2× 52 0.4× 191 1.4× 96 0.8× 15 662

Countries citing papers authored by V. Nuessler

Since Specialization
Citations

This map shows the geographic impact of V. Nuessler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Nuessler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Nuessler more than expected).

Fields of papers citing papers by V. Nuessler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Nuessler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Nuessler. The network helps show where V. Nuessler may publish in the future.

Co-authorship network of co-authors of V. Nuessler

This figure shows the co-authorship network connecting the top 25 collaborators of V. Nuessler. A scholar is included among the top collaborators of V. Nuessler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Nuessler. V. Nuessler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nuessler, V., et al.. (2006). Expression of MAC‐1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis. American Journal of Hematology. 81(4). 227–235. 30 indexed citations
2.
3.
4.
Pelka‐Fleischer, R., et al.. (2003). Low l‐selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk. European Journal Of Haematology. 71(5). 366–376. 10 indexed citations
5.
Salih, Helmut R., V. Nuessler, Claudio Denzlinger, et al.. (2003). Serum Levels of CD137 Ligand and CD178 are Prognostic Factors for Progression of Myelodysplastic Syndrome. Leukemia & lymphoma. 45(2). 301–308. 12 indexed citations
6.
Salih, Helmut R., Gary C. Starling, R. Pelka‐Fleischer, et al.. (2002). Differentiation of promyelocytic leukaemia: alterations in Fas (CD95/Apo‐1) and Fas Ligand (CD178) expression. British Journal of Haematology. 117(1). 76–85. 10 indexed citations
7.
Hasmann, Max, et al.. (2002). Cytoprotective features of selenazofurin in hematopoietic cells. International Journal of Clinical Pharmacology and Therapeutics. 40(8). 368–375. 3 indexed citations
8.
Stoetzer, Oliver J., et al.. (2002). Modulation of apoptosis by mitochondrial uncouplers: apoptosis-delaying features despite intrinsic cytotoxicity. Biochemical Pharmacology. 63(3). 471–483. 21 indexed citations
9.
Kaufmann, Andreas M., Peter L. Stern, Elaine M. Rankin, et al.. (2002). Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.. PubMed. 8(12). 3676–85. 170 indexed citations
10.
Salih, Helmut R., Helga Schmetzer, Christine Burke, et al.. (2001). Soluble CD137 (4-1BB) Ligand Is Released Following Leukocyte Activation and Is Found in Sera of Patients with Hematological Malignancies. The Journal of Immunology. 167(7). 4059–4066. 52 indexed citations
11.
Kaufmann, Andreas M., H. Sommer, V. Nuessler, et al.. (2001). Results of a phase II HPV vaccine trial with life recombinant vaccinia virus TA-HPV™. European Journal of Cancer. 37. S20–S20. 1 indexed citations
12.
13.
Nuessler, V., et al.. (1999). Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines. Leukemia. 13(11). 1864–1872. 42 indexed citations
14.
Zwierzina, H., et al.. (1999). Endogenous FLT-3 ligand serum levels are associated with disease stage in patients with myelodysplastic syndromes. Leukemia. 13(4). 553–557. 17 indexed citations
15.
Gieseler, Frank & V. Nuessler. (1999). Apoptosis research is saving the reputation of chemotherapy. Leukemia. 13(11). 1853–1853. 2 indexed citations
16.
Nuessler, V., et al.. (1999). Determination of thymidine phosphorylase activity in leukemic blast cells by a high-performance liquid-chromatographic assay. Chromatographia. 49(3-4). 173–178. 3 indexed citations
17.
Zwierzina, H., et al.. (1998). Endogenous serum thrombopoietin concentrations in patients with myelodysplastic syndromes. Leukemia. 12(1). 59–64. 18 indexed citations
18.
Croockewit, Alexandra, Miguel H. Bronchud, Matti Aapro, et al.. (1997). A European perspective on haematopoietic growth factors in haemato-oncology: Report of an expert meeting of the EORTC. European Journal of Cancer. 33(11). 1732–1746. 12 indexed citations
19.
Nuessler, V., R. Pelka‐Fleischer, F. del Valle, et al.. (1997). Expression and functional activity of P-glycoprotein in adult acute myelogenous leukemia patients. Annals of Hematology. 75(1-2). 17–26. 15 indexed citations
20.
Gieseler, Frank, Axel Glasmacher, H. Wandt, et al.. (1996). Topoisomerase II activities in AML and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines.. PubMed. 10(7). 1177–80. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Bartlett Breakdown of academic impact, for papers by Dieter Hoelzer Breakdown of academic impact, for papers by Simone Jüliger Breakdown of academic impact, for papers by CC Uphoff Breakdown of academic impact, for papers by K. Jurianz Breakdown of academic impact, for papers by Kathy S. Wang Breakdown of academic impact, for papers by Aloke Sarkar Breakdown of academic impact, for papers by Astrid Zahn Breakdown of academic impact, for papers by E P Rieber Breakdown of academic impact, for papers by Cécile Tétaud
Rankless by CCL
2026